~~<i id='13E79F7D74'><strike id='13E79F7D74'><tt id='13E79F7D74'><pre id='13E79F7D74'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：hotspot 2025-09-30 04:24:09 Page View：25339

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： A new ‘biological computer' targets cancer while sparing healthy cells
Next article： Duchenne breakthrough therapy leaves behind pioneering families

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Medicare drug price lawsuits could be good politics for Biden

AdobeWASHINGTON—PharmaceuticalcompaniesaredoinganythingtheycantostopPresidentBiden’sMedicareprogramf

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

ConsultantmembersoftheBritishMedicalAssociation(BMA)duringarallyattheBMAheadquartersinLondon,asconsu